2014
DOI: 10.1111/bph.12688
|View full text |Cite
|
Sign up to set email alerts
|

Novel lead structures and activation mechanisms for CO‐releasing molecules (CORMs)

Abstract: Carbon monoxide (CO) is an endogenous small signalling molecule in the human body, produced by the action of haem oxygenase on haem. Since it is very difficult to apply safely as a gas, solid storage and delivery forms for CO are now explored. Most of these CO-releasing molecules (CORMs) are based on the inactivation of the CO by coordinating it to a transition metal centre in a prodrug approach. After a brief look at the potential cellular target structures of CO, an overview of the design principles and acti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
194
0
2

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 231 publications
(199 citation statements)
references
References 100 publications
3
194
0
2
Order By: Relevance
“…For the controlled delivery and release of the toxic gas in aqueous environments, carbon monoxide-releasing molecules (CORMs) have proven to be the most promising for therapeutic usage (27,28). Transition metal carbonyl complexes are the most prominent CORMs because they can be triggered via light, solvent exchange on the metal coordination sphere, and enzymes (29,30). Macromolecular systems have also been exploited as CORM carriers to adapt CO release kinetics and retain toxic metabolites after CO release (27 (10,(31)(32)(33)(34).…”
Section: Discussionmentioning
confidence: 99%
“…For the controlled delivery and release of the toxic gas in aqueous environments, carbon monoxide-releasing molecules (CORMs) have proven to be the most promising for therapeutic usage (27,28). Transition metal carbonyl complexes are the most prominent CORMs because they can be triggered via light, solvent exchange on the metal coordination sphere, and enzymes (29,30). Macromolecular systems have also been exploited as CORM carriers to adapt CO release kinetics and retain toxic metabolites after CO release (27 (10,(31)(32)(33)(34).…”
Section: Discussionmentioning
confidence: 99%
“…All manganese atoms are embedded in distorted octahedral environments. The molecular structure and numbering scheme of the mixed-valent centrosymmetric complex [(MeOH) 4 Mn 4 (Br) 2 (OMe) 6 (2-PyPz Naph ) 2 ] (3b) is depicted in Figure 4; again symmetry related atoms are marked with the letter A. Two methoxide ligands occupy µ 3 -and four methoxide ions µ 2 -bridging positions.…”
Section: Degradation Of [(Oc)3mn(br)(2-pypz R H)] (R = Ph Naph) In Mmentioning
confidence: 99%
“…Metal carbonyls are usually considered for this purpose because numerous carbonyl ligands can be transported to a predetermined disease site and liberated via diverse triggers. Thus, CORMs are distinguished by the liberation initiators such as enzymes (ET-CORMs), illumination (photoCORMs), pH change, or substitution reactions (for recent reviews see [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17]). Especially photoCORMs represent a prominent group because a clean delivery of CO seems to be possible without the necessity to add another chemical trigger [8,[13][14][15].…”
Section: Introductionmentioning
confidence: 99%
“…Bunu, sitokrom oksidaza bağ-lanıp bu enzimi inhibe ederek yapmakta ve böyle-likle hücresel solunumu aksatmaktadır. 156 CO, hedef hücrede sGC bağlanarak onu aktive etmekte ve cGMP'yi artırmaktadır. 157 Bu mekanizmayı kullanarak CO hem nörotransmisyon hem de vazodilatasyon etkisi gerçekleşmektedir.…”
Section: Santral Si̇ni̇r Si̇stemi̇ Patoloji̇leri̇nde Hi̇drojen Sülfür İle İlunclassified